PB2411: THE EFFICACY OF MODIFIED MELPHALAN AND BUSULFAN-BASED CONDITIONING REGIMEN FOR AUTOLOGOUS-HSCT IN LOW-RISK AND INTERMEDIATE-RISK AML PATIENTS

• Weihua Zhai,
• Shulian Chen,
• Xiaoyu Zhang,
• Yi He,
• Sizhou Feng,
• Mingzhe Han,
• Xingli Zhao,
• Jie Bai,
• Lijuan LI,
• Zhihua Zhang,
• Ying Wang,
• Erlie Jiang,
• Jianxiang Wang

Affiliations

Weihua Zhai

1 Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Hematology, Tianjin, China

Shulian Chen

1 Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Hematology, Tianjin, China

Xiaoyu Zhang

1 Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Hematology, Tianjin, China

Yi He

1 Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Hematology, Tianjin, China

Sizhou Feng

1 Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Hematology, Tianjin, China

Mingzhe Han

1 Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Hematology, Tianjin, China

Xingli Zhao

2 Tianjin People’s Hospital, School of Medicine, Nankai University, Oncology and Hematology, Tianjin, China

Jie Bai

3 The Second Hospital of Tianjin Medical University, Hematology, Tianjin, China

Lijuan LI

4 Tianjin Medical University General Hospital, Hematology, Tianjin, China

Zhihua Zhang

5 The Affiliated Hospital of Chengde Medical College, Hematology, Chengde, China

Ying Wang

1 Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Hematology, Tianjin, China

Erlie Jiang

1 Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Hematology, Tianjin, China

Jianxiang Wang

1 Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Hematology, Tianjin, China